Evidence map›Paper›PMID 26823926›Full record

ReviewThe western journal of emergency medicine2016

Association of Insurance Status with Severity and Management in ED Patients with Asthma Exacerbation.

Kohei Hasegawa, Samantha J Stoll, Jason Ahn, Rashid F Kysia, Ashley F Sullivan, Carlos A Camargo

Open access · goldAbstract readMulticenter StudyReview
In one paragraph

Review in The western journal of emergency medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Status of Asthma in the United States.Preventing chronic disease · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Elaborate biologic approval process delays care of patients with moderate-to-severe asthma.The journal of allergy and clinical immunology. Global · 2023
    Article
  12. Article
  13. Observational
  14. Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals.The journal of allergy and clinical immunology. In practice · 2021
    Article
  15. Cost barriers to asthma care by health insurance type among children with asthma.The Journal of asthma : official journal of the Association for the Care of Asthma · 2020
    Article
  16. Article
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kohei HasegawaMassachusetts General Hospital, Harvard Medical School, Department of Emergency Medicine, Boston, Massachusetts.
Samantha J StollNorth Shore Medical Center, Department of Emergency Medicine, Salem, Massachusetts.
Jason AhnMassachusetts General Hospital, Harvard Medical School, Department of Emergency Medicine, Boston, Massachusetts.
Rashid F KysiaJohn H. Stroger Jr. Hospital of Cook County, Department of Emergency Medicine, Chicago, Illinois.
Ashley F SullivanMassachusetts General Hospital, Harvard Medical School, Department of Emergency Medicine, Boston, Massachusetts.
Carlos A CamargoMassachusetts General Hospital, Harvard Medical School, Department of Emergency Medicine, Boston, Massachusetts.
Harvard University · USMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrevious studies have demonstrated an association of low socioeconomic status with frequent asthma exacerbations. However, there have been no recent multicenter efforts to examine the relationship of insurance status - a proxy for socioeconomic status - with asthma severity and management in adults. The objective is to investigate chronic and acute asthma management disparities by insurance status among adults requiring emergency department (ED) treatment in the United States.

methodsWe conducted a multicenter chart review study (48 EDs in 23 U.S. states) on ED patients, aged 18-54 years, with acute asthma between 2011 and 2012. Each site underwent training (lecture, practice charts, certification) before reviewing randomly selected charts. We categorized patients into three groups based on their primary health insurance: private, public, and no insurance. Outcome measures were chronic asthma severity (as measured by ≥2 ED visits in one-year period) and management prior to the index ED visit, acute asthma management in the ED, and prescription at ED discharge.

resultsThe analytic cohort comprised 1,928 ED patients with acute asthma. Among these, 33% had private insurance, 40% had public insurance, and 27% had no insurance. Compared to patients with private insurance, those with public insurance or no insurance were more likely to have ≥2 ED visits during the preceding year (35%, 49%, and 45%, respectively; p<0.001). Despite the higher chronic severity, those with no insurance were less likely to have guideline-recommended chronic asthma care - i.e., lower use of inhaled corticosteroids (ICS [41%, 41%, and 29%; p<0.001]) and asthma specialist care (9%, 10%, and 4%; p<0.001). By contrast, there were no significant differences in acute asthma management in the ED - e.g., use of systemic corticosteroids (75%, 79%, and 78%; p=0.08) or initiation of ICS at ED discharge (12%, 12%, and 14%; p=0.57) - by insurance status.

conclusionIn this multicenter observational study of ED patients with acute asthma, we found significant discrepancies in chronic asthma severity and management by insurance status. By contrast, there were no differences in acute asthma management among the insurance groups.

Indexed as

Ambulatory CareAnti-Asthmatic AgentsAsthmaEmergency Service, HospitalEmergency TreatmentEvidence-Based PracticeHealthcare DisparitiesHospitalizationHumansInsurance CoveragePolicy MakingSeverity of Illness IndexUnited StatesAnti-Asthmatic Agents

Identifiers

PMID26823926
PMCPMC4729414
OpenAlexW2235272970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.